Your resource for capitalizing on the dynamic changes in healthcare delivery. Explore insights for Manufacturers, Providers, Health Systems & Pharmacies.

Latest Stories

View all
    • 2015 Specialty Pharma Forecast

      Making fact-based supply chain decisions means pharmaceutical manufacturers must have a bird’s-eye view of what’s going on in the industry. How will new regulations affect your distribution strategy this year? What innovation will impact the supply chain? We’ve taken a look at this year’s trends and logistics predictions to uncover six key facts that will drive manufacturers’ expectations in the coming year.
      by AmerisourceBergen
      • Chart
      • Photo
    • CMS Clarifies Biosimilar Coding and Reimbursement

      Three guidance documents were released by CMS on March 30 outlining coverage and reimbursement of biosimilars. Health Policy Weekly provides a summary of the guidance issued and addresses remaining areas of uncertainty.
      Stacie Heller by Stacie Heller
    • Connecting Care With Value

      Learn about the impact of CMS Star Ratings on health system ambulatory pharmacies and the connection to accountable care.
      Kevin Bisch by Kevin Bisch
    • The Who, When and Why of GPO Contract Data

      Learn what GPO contract data can show manufacturers about utilization and more. As with many other industries, data collection and analysis has become a critical tool for visibility in pharma. Not surprisingly, many providers are taking a closer look at the effectiveness of group purchasing organization (GPO) contracts as a way to collectively aggregate important information about the value of the drugs they administer and promote safer and more efficient administration of drugs to patients. Pharmaceutical manufacturers can capitalize on the visibility offered through GPO partnerships for access to the right information to help find opportunities for provider education, patient assistance, additional contract value and more.
      by AmerisourceBergen
    • Congress Close to Repealing SGR

      More on The SGR Repeal and Medicare Provider Payment Modernization Act of 2015, legislation introduced in both the House and Senate last week to repeal the sustainable growth rate (SGR) formula that has threatened Medicare payments to physicians since its inception in 1997.
      Stacie Heller by Stacie Heller
    • CONITEC: Redefining HTA and Understanding the Emerging Market in Brazil

      With an estimated population of over 200 million and a growing domestic economy, Brazil ranks as having the sixth largest pharmaceutical market globally and a healthcare sector that is presently evolving in how it addresses access to safe, effective medicines. Learn more about its managing agency, CONITEC.
      Roshan Rahnama by Roshan Rahnama